Skip to main content
Top
Published in: BMC Psychiatry 1/2008

Open Access 01-12-2008 | Research article

The incidence and prevalence of diabetes in patients with serious mental illness in North West Wales: Two cohorts, 1875–1924 & 1994–2006 compared

Authors: Joanna Le Noury, Afshan Khan, Margaret Harris, Winnie Wong, Dawn Williams, Tony Roberts, Richard Tranter, David Healy

Published in: BMC Psychiatry | Issue 1/2008

Login to get access

Abstract

Background

Against a background of interest in rates of diabetes in schizophrenia and related psychoses and claims that data from historical periods demonstrate a link that antedates modern antipsychotics, we sought to establish the rate of diabetes in first onset psychosis and subsequent prevalence in historical and contemporary cohorts.

Methods

Analysis of two epidemiologically complete databases of individuals admitted for mental illness. 3170 individuals admitted to the North Wales Asylum between 1875–1924 and tracked over 18,486 patient years and 394 North West Wales first admissions for schizophrenia and related psychoses between 1994 and 2006 and tracked after treatment.

Results

The prevalence of Type 2 diabetes among patients with psychoses at time of first admission in both historical and contemporary samples was 0%. The incidence of diabetes remained 0% in the historical sample throughout 15 years of follow-up but rose in the contemporary sample after 3, 5 and 6 years of treatment with an incidence rate double the expected population rate so that the 15 year prevalence is likely to be over 8%.

Conclusion

No association was found between diabetes and serious mental illness, but there may be an association between diabetes and treatment.
Literature
1.
go back to reference Serynak MJ, Leslie DL, Alarcon RD, Losonczy MF, Rosenheck RA: Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia. Am J Psychiatry. 2002, 159: 561-566. 10.1176/appi.ajp.159.4.561.CrossRef Serynak MJ, Leslie DL, Alarcon RD, Losonczy MF, Rosenheck RA: Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia. Am J Psychiatry. 2002, 159: 561-566. 10.1176/appi.ajp.159.4.561.CrossRef
2.
go back to reference Goff DC, Sullivan LM, McEvoy JP, Meyer JM, Nasrallah HA, Daumit GL, Lamberti S, D'Agostino RB, Stroup TS, Davis S, Lieberman JA: A comparison of ten year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls. Schizophrenia Res. 2005, 80: 45-53. 10.1016/j.schres.2005.08.010.CrossRef Goff DC, Sullivan LM, McEvoy JP, Meyer JM, Nasrallah HA, Daumit GL, Lamberti S, D'Agostino RB, Stroup TS, Davis S, Lieberman JA: A comparison of ten year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls. Schizophrenia Res. 2005, 80: 45-53. 10.1016/j.schres.2005.08.010.CrossRef
3.
go back to reference Holt RI, Bushe C, Citrome L: Diabetes and schizophrenia 2005: are we any closer to understanding the link. J Psychopharmacology. 2005, 19: S56-S65. 10.1177/0269881105058379.CrossRef Holt RI, Bushe C, Citrome L: Diabetes and schizophrenia 2005: are we any closer to understanding the link. J Psychopharmacology. 2005, 19: S56-S65. 10.1177/0269881105058379.CrossRef
4.
go back to reference De Hert M, van Winkel R, Van Eyck D, Hanssens L, Wampers M, Scheen A, Peuskens J: Prevalence of diabetes, metabolic syndrome and metabolic abnormalities in schizophrenia over the course of the illness: a cross-sectional study. Clin Pract Epidemol Ment Health. 2006, 2: 14-10.1186/1745-0179-2-14.CrossRef De Hert M, van Winkel R, Van Eyck D, Hanssens L, Wampers M, Scheen A, Peuskens J: Prevalence of diabetes, metabolic syndrome and metabolic abnormalities in schizophrenia over the course of the illness: a cross-sectional study. Clin Pract Epidemol Ment Health. 2006, 2: 14-10.1186/1745-0179-2-14.CrossRef
5.
go back to reference Kenny SJ, Aubert RE, Geiss LS: Prevalence and incidence of non-insulin-dependent diabetes. Diabetes in America. Edited by: Harris M, Cowie C, Reiber G, Boyko E, Stern M, Bennett P. 1995, Washington D.C, US Government Printing Office, 47-68. Kenny SJ, Aubert RE, Geiss LS: Prevalence and incidence of non-insulin-dependent diabetes. Diabetes in America. Edited by: Harris M, Cowie C, Reiber G, Boyko E, Stern M, Bennett P. 1995, Washington D.C, US Government Printing Office, 47-68.
7.
go back to reference Healy D, Savage M, Michael P, Harris M, Hirst D, Carter M, Cattell D, McMonagle T, Sohler N, Susser E: Psychiatric bed utilisation: 1896 and 1996 compared. Psychol Med. 2001, 31: 779-790. 10.1017/S0033291701003968.CrossRefPubMed Healy D, Savage M, Michael P, Harris M, Hirst D, Carter M, Cattell D, McMonagle T, Sohler N, Susser E: Psychiatric bed utilisation: 1896 and 1996 compared. Psychol Med. 2001, 31: 779-790. 10.1017/S0033291701003968.CrossRefPubMed
8.
go back to reference Citrome L, Jaffe A, Levine J, Allingham B, Robinson J: Relationship between antipsychotic medication treatment and new cases of diabetes among psychiatric inpatients. Psychiatric Services. 2004, 55: 1006-013. 10.1176/appi.ps.55.9.1006.CrossRefPubMed Citrome L, Jaffe A, Levine J, Allingham B, Robinson J: Relationship between antipsychotic medication treatment and new cases of diabetes among psychiatric inpatients. Psychiatric Services. 2004, 55: 1006-013. 10.1176/appi.ps.55.9.1006.CrossRefPubMed
9.
go back to reference Leslie DL, Rosenheck RA: Incidence of newly diagnosed diabetes attributable to atypical antipsychotic medications. Am J Psychiatry. 2004, 161: 1709-1711. 10.1176/appi.ajp.161.9.1709.CrossRefPubMed Leslie DL, Rosenheck RA: Incidence of newly diagnosed diabetes attributable to atypical antipsychotic medications. Am J Psychiatry. 2004, 161: 1709-1711. 10.1176/appi.ajp.161.9.1709.CrossRefPubMed
10.
go back to reference Arranz B, Rosel P, Ramirez N, Duenas R, Fernandez P, Sanchez JM, Navarro MA, San L: Insulin resistance and increased leptin concentrations in non-compliant schizophrenia patients but not in antipsychotic naïve first episode schizophrenia patients. J Clinical Psychiatry. 2004, 65: 1335-1342.CrossRef Arranz B, Rosel P, Ramirez N, Duenas R, Fernandez P, Sanchez JM, Navarro MA, San L: Insulin resistance and increased leptin concentrations in non-compliant schizophrenia patients but not in antipsychotic naïve first episode schizophrenia patients. J Clinical Psychiatry. 2004, 65: 1335-1342.CrossRef
11.
go back to reference Zhang ZJ, Yao ZJ, Liu W, Fang Q, Reynolds GP: Effects of antipsychotics on fat deposition and changes in leptin and insulin levels. Magnetic resonance imaging study of previously untreated people with schizophrenia. Brit J Psychiatry. 2004, 184: 58-62. 10.1192/bjp.184.1.58.CrossRef Zhang ZJ, Yao ZJ, Liu W, Fang Q, Reynolds GP: Effects of antipsychotics on fat deposition and changes in leptin and insulin levels. Magnetic resonance imaging study of previously untreated people with schizophrenia. Brit J Psychiatry. 2004, 184: 58-62. 10.1192/bjp.184.1.58.CrossRef
12.
go back to reference Kooy FH: Hyperglycemia in mental disorders. Brain. 1919, 42: 214-289. 10.1093/brain/42.3.214.CrossRef Kooy FH: Hyperglycemia in mental disorders. Brain. 1919, 42: 214-289. 10.1093/brain/42.3.214.CrossRef
13.
go back to reference Drury KK, Farron-Ridge C: Some observations of the types of blood-sugar curves found in different forms of insanity. J Ment Sci. 1925, 71: 8-29. Drury KK, Farron-Ridge C: Some observations of the types of blood-sugar curves found in different forms of insanity. J Ment Sci. 1925, 71: 8-29.
14.
go back to reference Raphael T, Parsons JP: Blood sugar studies in dementia praecox and manic-depressive insanity. Arch Neurology & Psychiatry. 1921, 5: 687-709.CrossRef Raphael T, Parsons JP: Blood sugar studies in dementia praecox and manic-depressive insanity. Arch Neurology & Psychiatry. 1921, 5: 687-709.CrossRef
15.
go back to reference Lorenz WF: Sugar tolerance in dementia praecox and other mental states. Arch Neurology & Psychiatry. 1922, 8: 184-196.CrossRef Lorenz WF: Sugar tolerance in dementia praecox and other mental states. Arch Neurology & Psychiatry. 1922, 8: 184-196.CrossRef
16.
go back to reference Barrett TB, Serre P: Blood analysis and sugar tolerance in mental disease. J Nerv & Ment Disease. 1924, 59: 561-570. 10.1097/00005053-192406000-00001.CrossRef Barrett TB, Serre P: Blood analysis and sugar tolerance in mental disease. J Nerv & Ment Disease. 1924, 59: 561-570. 10.1097/00005053-192406000-00001.CrossRef
17.
go back to reference Kasanin J: The blood sugar curve in mental disease. II. The schizophrenia (dementia praecox) groups. Arch Neurology & Psychiatry. 1926, 16: 414-419.CrossRef Kasanin J: The blood sugar curve in mental disease. II. The schizophrenia (dementia praecox) groups. Arch Neurology & Psychiatry. 1926, 16: 414-419.CrossRef
18.
go back to reference Courvoisier S, Fournel J, Ducrot R: Pharmacodynamic properties of 3-chloro-10-(3-dimethylaminopropyl)-phenothiazine hydrochloride (R.P. 4560); experimental study of a new substance used in potentialized anesthesia and in artificial hibernation. Arch Int Pharmacodynamic Therapy. 1953, 92: 305-361. Courvoisier S, Fournel J, Ducrot R: Pharmacodynamic properties of 3-chloro-10-(3-dimethylaminopropyl)-phenothiazine hydrochloride (R.P. 4560); experimental study of a new substance used in potentialized anesthesia and in artificial hibernation. Arch Int Pharmacodynamic Therapy. 1953, 92: 305-361.
20.
go back to reference Giacobini E, Lassenius B: Chlorpromazine treatment; side effects and complications. Nordic Medicine. 1954, 52: 1693-1699. Giacobini E, Lassenius B: Chlorpromazine treatment; side effects and complications. Nordic Medicine. 1954, 52: 1693-1699.
21.
go back to reference Merivale WH, Hunter RA: Abnormal glucose tolerance tests in patients treated with sedative drugs. Lancet. 1954, ii: 939-942. 10.1016/S0140-6736(54)92554-4.CrossRef Merivale WH, Hunter RA: Abnormal glucose tolerance tests in patients treated with sedative drugs. Lancet. 1954, ii: 939-942. 10.1016/S0140-6736(54)92554-4.CrossRef
22.
go back to reference Charatan FBE, Bartlett NG: The effect of chlorpromazine ('Largactil') on glucose tolerance. J Ment Sci. 1955, 101: 351-353.PubMed Charatan FBE, Bartlett NG: The effect of chlorpromazine ('Largactil') on glucose tolerance. J Ment Sci. 1955, 101: 351-353.PubMed
23.
go back to reference Hiles BW: Hyperglycemia and glycosuria following chlorpromazine therapy. JAMA. 1956, 62: 1651-CrossRef Hiles BW: Hyperglycemia and glycosuria following chlorpromazine therapy. JAMA. 1956, 62: 1651-CrossRef
24.
go back to reference Eaton WW, Byrne M, Ewald H, Mors O, Chen C-Y, Agerbo E, Mortensen PB: Association of schizophrenia and autoimmune diseases: linkage of Danish national registers. Am J Psychiatry. 2006, 163: 521-528. 10.1176/appi.ajp.163.3.521.CrossRefPubMed Eaton WW, Byrne M, Ewald H, Mors O, Chen C-Y, Agerbo E, Mortensen PB: Association of schizophrenia and autoimmune diseases: linkage of Danish national registers. Am J Psychiatry. 2006, 163: 521-528. 10.1176/appi.ajp.163.3.521.CrossRefPubMed
Metadata
Title
The incidence and prevalence of diabetes in patients with serious mental illness in North West Wales: Two cohorts, 1875–1924 & 1994–2006 compared
Authors
Joanna Le Noury
Afshan Khan
Margaret Harris
Winnie Wong
Dawn Williams
Tony Roberts
Richard Tranter
David Healy
Publication date
01-12-2008
Publisher
BioMed Central
Published in
BMC Psychiatry / Issue 1/2008
Electronic ISSN: 1471-244X
DOI
https://doi.org/10.1186/1471-244X-8-67

Other articles of this Issue 1/2008

BMC Psychiatry 1/2008 Go to the issue